The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes

Diabetes Care. 2004 May;27(5):1202-4. doi: 10.2337/diacare.27.5.1202.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arginine* / administration & dosage
  • C-Peptide / blood
  • Diabetes Mellitus, Type 1 / blood*
  • Glucose Tolerance Test / methods*
  • Humans
  • Injections, Intravenous
  • Postprandial Period
  • Reproducibility of Results
  • Treatment Outcome

Substances

  • C-Peptide
  • Arginine